FDA approves new Alzheimer’s drug from Eli Lilly
TheStreet’s Conway Gittens brings you the biggest news of the day, including what investors are watching and Eli Lilly’s new Alzheimer’s drug gets FDA approval.
![Avatar - TheStreet](https://cdn.statically.io/img/cdn.flipboard.com/uploads/avatar/76190da93c722fb9e80e286fd79c247b1975d952.jpeg)
TheStreet flipped this story into The Street Videos•5d
More stories from TheStreet
Join the flipboard community
Discover, collect, and share stories for all your interests
Sign upMore stories from Eli Lilly
Eli Lilly Shows Appetite for Oral Immunology Drugs, Swallowing Morphic in $3.2B Deal
Eli Lilly’s Morphic acquisition brings an oral small molecule that blocks the same target as Entvyio, an injectable inflammatory bowel disease drug …
- Alabama Reflectorflipped into Latest from Alabama
‘Compounded’ weight-loss drugs are a growing problem for state regulators
Anna Wysock’s “aha” moment arrived in an Ohio amusement park, as she got ready to ride a roller coaster with her 7-year-old son: The safety bar …
Eli Lilly to buy Waltham-based drug developer for $3.2B
WALTHAM, Mass. — Drug manufacturer Eli Lilly is moving to buy Waltham-based biotech company Morphic Holding Inc. in a $3.2 billion deal. According to a …